El trading conlleva riesgos
Los CFDs son instrumentos complejos y tienen un alto riesgo de perder dinero rápidamente debido al apalancamiento.
El trading conlleva riesgos
Los CFDs son instrumentos complejos y tienen un alto riesgo de perder dinero rápidamente debido al apalancamiento.
Español (Latinoamérica)
Merit Medical Systems Inc
Cerrado
SectorSalud
72.64 -1.05
Resumen
Variación precio
24h
Mínimo
70.87
Máximo
73.91
Ingresos | 10M 38M |
|---|---|
Ventas | 9.8M 394M |
P/B Media del Sector | 35.916 66.845 |
Margen de beneficio | 9.648 |
Empleados | 7,500 |
EBITDA | 12M 92M |
Recomendaciones | Compra Fuerte |
|---|---|
Estimación a 12 meses | +40.01% upside |
Próximas Ganancias | 23 abr 2026 |
|---|
Capitalización de Mercado | -292M 4.5B |
|---|---|
Apertura anterior | 73.69 |
Cierre anterior | 72.64 |
Noticias sobre sentimiento de mercado
By Acuity
50%
50%
154 / 351 Clasificación en Healthcare
Puntuación técnica
By Trading Central
Confianza
Strong Bullish Evidence
Merit Medical Systems Inc Gráfico
El rendimiento pasado no es un indicador fiable de resultados futuros.
Noticias Relacionadas
Comparación entre iguales
Cambio de precio
Merit Medical Systems Inc Esperado
Precio Objetivo
By TipRanks
40.01% repunte
Estimación a 12 meses
Media 102.89 USD 40.01%
Máximo 122 USD
Mínimo 78 USD
De acuerdo con 9 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Merit Medical Systems Inc Dist en los últimos 3 meses.
Sentimiento
By Acuity
154 / 351 Clasificación en Salud
Noticias sobre sentimiento de mercado
Neutral
Volatilidad
Por debajo de la media
Volumen de Noticias (RCV)
Por debajo de la media
Finanzas
Gastos de venta y administración
Gastos operativos
Beneficio antes de impuestos
Ventas
Coste de ventas
Beneficio bruto de ventas
Gasto por intereses de deuda
EBITDA
Beneficio operativo
$
Acerca de Merit Medical Systems Inc
Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. It also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems. In addition, the company provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate structures; gastroenterology products, such as covered esophageal stents, syringe and gauges, and balloon dilators; and kits and accessories for endoscopy and bronchoscopy procedures. It sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers. The company was incorporated in 1987 and is headquartered in South Jordan, Utah.
Live chat